LEADER 04481nam  2200649Ia 450 
001 9910140835903321
005 20230725024606.0
010   $a1-118-07434-3
010   $a1-299-18614-9
010   $a0-470-87578-X
010   $a0-470-87577-1
035   $a(CKB)2670000000035446
035   $a(EBL)573793
035   $a(OCoLC)659500775
035   $a(SSID)ssj0000424645
035   $a(PQKBManifestationID)11294627
035   $a(PQKBTitleCode)TC0000424645
035   $a(PQKBWorkID)10474509
035   $a(PQKB)10955921
035   $a(MiAaPQ)EBC573793
035   $a(Au-PeEL)EBL573793
035   $a(CaPaEBR)ebr10419119
035   $a(CaONFJC)MIL449864
035   $a(EXLCZ)992670000000035446
100   $a20100804d2010      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aOrganelle-specific pharmaceutical nanotechnology$b[electronic resource] /$fedited by Volkmar Weissig, Gerard G.M. D'Souza
210   $aHoboken, NJ $cWiley$d2010
215   $a1 online resource (638 p.)
300   $aDescription based upon print version of record.
311   $a0-470-63165-1 
327   $aORGANELLE-SPECIFIC PHARMACEUTICAL NANOTECHNOLOGY; CONTENTS; PREFACE; CONTRIBUTORS; CHAPTER 1: An Introduction to Subcellular Nanomedicine: Current Trends and Future Developments; CHAPTER 2: Delivery of Nanosensors to Measure the Intracellular Environment; CHAPTER 3: Cytoplasmic Diffusion of Dendrimers and Dendriplexes; CHAPTER 4: Endocytosis and Intracellular Trafficking of Quantum Dot-Ligand Bioconjugates; CHAPTER 5: Synthesis of Metal Nanoparticle-Based Intracellular Biosensors and Therapeutic Agents; CHAPTER 6: Subcellular Fate of Nanodelivery Systems
327   $aCHAPTER 7: Intracellular Fate of Plasmid DNA PolyplexesCHAPTER 8: Intracellular Traffi cking of Membrane Receptor-Mediated Uptake of Carbon Nanotubes; CHAPTER 9: Real-Time Particle Tracking for Studying Intracellular Transport of Nanotherapeutics; CHAPTER 10: Tracking Intracellular Polymer Localization Via Fluorescence Microscopy; CHAPTER 11: Can QSAR Models Describing Small-Molecule Xenobiotics Give Useful Tips for Predicting Uptake and Localization of Nanoparticles in Living Cells? And If Not, Why Not?; CHAPTER 12: Self-Unpacking Gene Delivery Scaffolds
327   $aCHAPTER 13: Cellular Trafficking of DendrimersCHAPTER 14: Endolysosomolytically Active pH-Sensitive Polymeric Nanotechnology; CHAPTER 15: Uptake and Intracellular Dynamics of Proteins Internalized by Cell-Penetrating Peptides; CHAPTER 16: Cargo Transport by Teams of Molecular Motors: Basic Mechanisms for Intracellular Drug Delivery; CHAPTER 17: The Potential of Photochemical Internalization (PCI) for the Cytosolic Delivery of Nanomedicines; CHAPTER 18: Peptide-Based Nanocarriers for Intracellular Delivery of Biologically Active Proteins
327   $aCHAPTER 19: Organelle-Specific Pharmaceutical Nanotechnology: Active Cellular Transport of Submicro- and Nanoscale ParticlesCHAPTER 20: Subcellular Targeting of Virus-Envelope-Coated Nanoparticles; CHAPTER 21: Mitochondria-Targeted Pharmaceutical Nanocarriers; CHAPTER 22: Cell-Penetrating Peptides for Cytosolic Delivery of Biomacromolecules; CHAPTER 23: Therapeutic Nano-object Delivery to Subdomains of Cardiac Myocytes; CHAPTER 24: Design Parameters Modulating Intracellular Drug Delivery: Anchoring to Specific Cellular Epitopes, CarrierGeometry, and Use of Auxiliary Pharmacological Agents
327   $aCHAPTER 25: Uptake Pathways Dependent Intracellular Trafficking of DNA Carrying Nanodelivery SystemsCHAPTER 26: Cellular Interactions of Plasmon-Resonant Gold Nanorods; CHAPTER 27: Quantum Dot Labeling for Assessment of Intracellular Trafficking of Therapeutically Active Molecules; INDEX
330   $aThis book introduces and discusses the latest in biomedical research--Pharmaceutical Nanotechnology applied at the sub-cellular level.
606   $aPharmaceutical technology
606   $aNanotechnology
606   $aDrug targeting
615  0$aPharmaceutical technology.
615  0$aNanotechnology.
615  0$aDrug targeting.
676   $a615/.19
701   $aWeissig$b Volkmar$0864494
701   $aD'Souza$b Gerard G. M$0864495
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910140835903321
996   $aOrganelle-specific pharmaceutical nanotechnology$91929476
997   $aUNINA